FindTrial
Sign In

A Randomized controlled study on Brihat HaridraKhanda And Haridrakhanda in the management of Chronic Urticaria (Sheet Pitta,Udarda,Kotha)

A RANDOMIZED CONTROLLED STUDY ON BRIHAT HARIDRAKHANDA IN THE MANAGEMENT OF CHRONIC URTICARIA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021642
Enrollment
30
Registered
2019-10-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

Intervention1: Group-B Haridrakhand: Orally 4 Gram Thrice in a day after meal with Usnodak for 30Days. Control Intervention1: Group-A Brihat Haridrakhand: Orally 4 Gram Thrice in a day after meal with

Sponsors

Parul Institute of Ayurved
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed case of Chronic Urticaria patients will be selected.

Exclusion criteria

Exclusion criteria: Major systemic illness like CRF, DM, Thyroid related disease. History of Anaphylaxis to medicine and food. Patients suffering from other skin diseases such as eczema, Psoriasis or other skin disease.

Design outcomes

Primary

MeasureTime frame
All the signs and symptoms of chronic urticaria will be assigned score depending upon their severity to assess the effect of the drugs at the time of Before and After treatment.Timepoint: 30 Days—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactVd Prakash Kumbar

Parul Institute of Ayurved

drprakash.kc@gmail.com9916204070

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026